A 45 year-old woman presented for evaluation of poorly controlled temporal lobe seizures, despite taking three anticonvulsant medications. Her seizures always started with a "deja vu" feeling, ...
- First subject received unilateral administration of NRTX-1001 in a new non-MTS cohort; no significant surgical complications or adverse events reported to date - - Data from this non-MTS cohort, ...
The present study was designed to evaluate the genetic mechanisms in patients with focal epileptiform discharges in the mid-temporal or central regions, an electroencephalographic abnormality of high ...
SAN FRANCISCO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback